Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
7,201	46.35498	1	male	0	5	260	Lung Cancer	Cancer	2	12	under $11k	0	5,674	3,828.9844	4,581.27734	28	white	20.898438	18	0.672974	0.373962	1	0	0	metastatic	0.9	0.9	no dnr	5	65	12.199219	114	42	36.09375	314.25	4.299805	0.899902	2.199707	132	7.419922	315	46	80	0	0	no(M2 and SIP pres)	0
7,202	70.97894	0	male	0	8	746	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	8,574	6,221.0352	6,140.19922	14	white	12.798828	20	0.886963	0.810913	1	0	0	yes	0.9	0.8	no dnr	8	56	12.099609	65	30	34.09375	48	1.399902	1	1.5	148	7.329102	259	15	855	2	null	null	1.838867
7,203	68.91199	0	male	0	4	746	CHF	COPD/CHF/Cirrhosis	2	9	under $11k	0	3,216	2,273.0098	2,179.63867	9	white	21.199219	15	0.835938	0.730957	1	0	0	no	0.5	0.5	no dnr	4	103	8	122	24	35.19531	null	2	0.5	0.5	132	null	345	7	4,215	0	0	SIP>=30	0
7,204	85.26495	1	female	0	8	517	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	under $11k	89	9,667	6,643.6367	6,619.07812	16	black	16.097656	23	0.550903	0.437988	1	0	1	no	0.3	0.2	dnr after sadm	1	105	4.5	61	24	36.69531	252.375	2.899902	0.799927	2.299805	140	7.389648	85	48	2,200	null	6	adl>=4 (>=5 if sur)	6
7,205	45.02698	0	female	0	48	743	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	under $11k	44	58,833	40,751.25	44,380.3438	30.25	white	25.5	62	0.733887	0.651978	1	0	0	no	0	0	dnr after sadm	11	61	5.699219	48	24	36.19531	319	4	0.699951	1.399902	142	7.379883	179	18	null	null	3	adl>=4 (>=5 if sur)	3
7,206	48.33698	1	female	0	63	164	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	>$50k	0	124,981	83,853.9375	93,904.375	43.75	white	28.597656	39	0.783936	0.713989	2	1	0	no	1	1	no dnr	63	130	14.398438	73	30	38.39844	372	null	null	0.899902	140	7.419922	155	39	2,475	null	6	adl>=4 (>=5 if sur)	6
7,207	38.58499	0	male	0	11	728	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	34,372	22,292.2031	24,260.3594	26.5	white	19.296875	37	0.890991	0.851929	9	0	0	no	0.8	0.7	no dnr	11	53	13.599609	136	44	36.59375	127.5	3.599609	1	2.299805	135	7.439453	226	46	2,537	null	0	no(M2 and SIP pres)	0
7,208	30.754	1	male	0	6	7	MOSF w/Malig	ARF/MOSF	1	10	under $11k	9	7,459	4,904.0312	6,021.66797	9	white	31.199219	50	0.459961	0.339966	1	0	0	metastatic	0.1	0	dnr after sadm	4	107	13.5	64	20	36.19531	144.4375	2.099609	2.199707	0.5	131	7.529297	158	8	3,600	0	5	<2 mo. follow-up	5
7,209	34.93997	1	male	1	3	3	Coma	Coma	0	12	null	100	45,217	29,206.0625	32,382.0781	38	black	22.898438	41	0.441956	0.367981	10	0	0	no	null	null	no dnr	3	118	7	60	33	35.79688	134.6875	2.599609	13	0.599976	136	7.479492	180	15	1,305	null	null	<2 mo. follow-up	2.626953
7,210	70.62598	0	male	0	7	726	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	13,183	8,607.6953	9,377.92969	16.5	black	23.898438	30	0.762939	0.687988	3	0	1	no	0.8	0.75	no dnr	7	63	27.398438	96	22	36	157.5	2.199707	0.599976	1.799805	123	7.489258	307	7	3,480	0	1	no(M2 and SIP pres)	1
7,211	57.84299	1	female	1	5	5	Coma	Coma	1	12	>$50k	94	27,572	17,283.375	20,537.25	40	white	29.898438	31	0.097992	0.057999	5	0	0	no	1	0.5	no dnr	5	68	13.599609	69	28	39.89844	506.625	null	null	0.899902	137	7.439453	161	12	2,660	null	0	<2 mo. follow-up	0
7,212	78.60394	1	male	0	9	186	COPD	COPD/CHF/Cirrhosis	0	10	$11-$25k	9	20,281	12,641.4688	15,002.5938	26	white	28	24	0.578979	0.385986	2	0	0	no	0.9	0.7	no dnr	9	37	28.296875	129	8	35.40625	188.5625	1.699951	2.299805	4.199219	123	7.189453	111	48	115	1	2	no(M2 and SIP pres)	2
7,213	42.41498	0	male	0	4	726	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	3,282	2,309.2637	2,221.83984	8	white	21.898438	21	0.899902	0.831909	1	0	0	no	0.95	0.9	no dnr	4	68	16	117	40	39	175	2	0.399963	0.699951	138	7.429688	104	7	2,780	0	1	no(M2 and SIP pres)	1
7,214	30.30299	0	male	0	24	725	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	52,302	32,196.7656	36,270.9375	35.666657	white	28.597656	51	0.852905	0.80188	1	0	0	no	0.8	0.7	no dnr	24	105	6.399414	112	32	35.19531	164.5	null	1.099854	0.599976	133	7.259766	150	16	680	null	7	adl>=4 (>=5 if sur)	7
7,215	62.66098	1	male	0	5	499	CHF	COPD/CHF/Cirrhosis	8	8	under $11k	0	4,819	3,246.1875	2,970.11914	15	white	25	21	0.807983	0.689941	1	1	0	no	0.7	0.7	no dnr	5	86	12.398438	74	24	37	319	3.899902	1	1	133	7.459961	111	14	1,325	0	null	no(M2 and SIP pres)	0.494751
7,216	22.03099	0	male	0	52	724	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	111,446	72,256.6875	85,039.8125	25.75	white	24.199219	27	0.909912	0.876953	1	0	0	no	0.7	0.5	no dnr	52	103	5.299805	110	20	36.19531	237.125	2.799805	0.799927	1.799805	142	7.429688	74	34	1.899902	7	7	no(M2 and SIP pres)	7
7,217	62.98398	1	male	1	32	32	MOSF w/Malig	ARF/MOSF	1	18	$11-$25k	0	160,668	102,005.562	112,419.062	39.25	white	28.5	31	0.493958	0.375977	15	0	0	yes	0.7	0.7	dnr after sadm	27	69	4.899414	106	32	37.69531	385.6875	1.899902	36.695313	1.399902	149	7.379883	106	12	4,580	0	0	<2 mo. follow-up	0
7,218	54.793	0	male	0	4	721	COPD	COPD/CHF/Cirrhosis	2	11	under $11k	0	3,509	2,266.6348	2,573.99805	8	white	16.5	14	0.925903	0.873901	1	0	0	no	null	null	no dnr	4	85	10.298828	104	28	37.5	109.51562	4.299805	0.599976	1.099854	133	7.349609	76	11	null	0	1	no(M2 and SIP pres)	1
7,219	70.97296	1	female	0	23	74	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	44,927	26,642.4688	30,721.4062	32.333313	white	29.699219	55	0.539917	0.425964	1	1	0	metastatic	0.2	0.1	no dnr	23	101	5.599609	74	20	37	null	3.799805	0.5	1.099854	137	null	105	15	null	null	2	adl>=4 (>=5 if sur)	2
7,220	53.40698	0	male	0	10	720	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	16,622	10,085.3672	10,944.2188	24	black	27.699219	32	0.793945	0.725952	1	0	0	no	0.9	0.85	no dnr	10	83	6.699219	104	20	36.29688	null	2.599609	1.099854	1.299805	133	null	129	13	null	1	2	null	2
7,221	57.57199	0	male	0	3	720	COPD	COPD/CHF/Cirrhosis	5	10	$25-$50k	0	3,402	2,083.3262	2,233.85938	null	black	14.199219	21	0.931885	0.884888	1	0	0	no	null	null	no dnr	3	107	30.597656	131	28	36.39844	371.375	1.799805	3.199707	1.099854	130	7.449219	146	32	2,284	null	null	null	3.177734
7,222	81.32495	1	female	1	45	45	ARF/MOSF w/Sepsis	ARF/MOSF	3	6	under $11k	41	98,873	62,997.375	72,400.25	31	black	23.398438	56	0.603882	0.497986	1	1	0	no	0.65	0.5	dnr after sadm	40	76	10.099609	70	24	36.59375	307.375	2.799805	0.699951	2.099609	147	7.359375	99	54	1,010	null	7	<2 mo. follow-up	7
7,223	50.58197	1	female	0	16	65	COPD	COPD/CHF/Cirrhosis	1	9	under $11k	26	43,719	27,188.3125	31,952.6562	32	black	25.199219	28	0.822998	0.711914	1	0	0	no	0.85	0.8	no dnr	16	63	11.199219	114	24	36.59375	null	3.799805	0.899902	1.899902	139	null	119	20	1,650	null	null	null	3.202148
7,224	62.51898	1	female	0	4	46	Colon Cancer	Cancer	2	9	under $11k	9	3,170	2,188.7773	2,841.35938	16	hispanic	24.597656	25	0.659912	0.356995	1	1	0	metastatic	0.6	0.2	dnr after sadm	2	69	7.399414	71	32	35.59375	null	4.299805	1.299805	1.5	139	null	88	23	null	7	2	<2 mo. follow-up	2
7,225	80.08197	0	female	0	11	718	CHF	COPD/CHF/Cirrhosis	4	4	null	0	16,537	8,672.2656	11,048.1172	25	black	16.199219	19	0.858887	0.766968	1	0	1	no	0.8	0.7	no dnr	11	69	5.399414	114	24	36.09375	null	null	null	0.799927	142	null	113	12	null	2	3	SIP>=30	3
7,226	45.42099	0	male	0	15	717	CHF	COPD/CHF/Cirrhosis	2	10	$11-$25k	0	27,278	13,349.4062	17,523.5	18	white	9.099609	20	0.960938	0.932983	1	0	0	no	0.8	0.6	no dnr	15	72	22.199219	121	10	36	218	1.599854	1.399902	2.899902	130	7.389648	393	49	473	0	0	no(M2 and SIP pres)	0
7,227	77.52997	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	89,850	57,595.7188	65,648.25	50	white	33	63	0.449951	0.329956	19	0	0	no	0.5	0.3	dnr after sadm	8	115	10.398438	100	20	36.5	288.875	4.599609	1.099854	0.899902	142	7.459961	103	12	null	null	0	<2 mo. follow-up	0
7,228	36.99698	1	female	1	6	6	Coma	Coma	2	11	under $11k	0	33,561	22,041.4844	25,715.2188	47	black	41.59375	83	0.294983	0.224976	12	0	0	yes	0.05	0.05	dnr after sadm	2	71	null	70	22	36.29688	155.09375	null	null	1.699951	136	7.429688	116	53	1,390	null	0	<2 mo. follow-up	0
7,229	37.18799	1	male	1	55	55	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	158,605	99,295.6875	118,364	38	white	37.796875	61	0.660889	0.562988	2	0	0	no	0.5	0.45	dnr after sadm	54	166	19.5	120	32	36.89844	264	3	0.5	2.299805	142	7.539062	356	40	4,598	null	2	<2 mo. follow-up	2
7,230	72.68994	1	male	0	25	111	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	37	24,423	16,853.5938	19,758.6562	11.5	white	28	44	0.556885	0.444946	1	1	0	no	0.15	0.1	dnr after sadm	1	51	1	124	22	37.79688	125	2.5	2.699707	2.199707	133	7.379883	102	47	2,105	null	6	adl>=4 (>=5 if sur)	6
7,231	81.24799	0	male	0	55	714	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	null	37	113,127	72,381.75	87,078.375	41.25	white	22.796875	41	0.453979	0.334961	2	0	0	metastatic	0.8	0.8	no dnr	55	116	16.097656	73	24	38.09375	233.3125	3	0.699951	1.399902	148	7.459961	186	31	1,998	null	0	SIP>=30	0
7,232	52.33398	1	male	0	5	391	CHF	COPD/CHF/Cirrhosis	3	11	under $11k	0	4,861	2,851.1953	2,987.98828	8	black	8.599609	12	0.956909	0.924927	1	1	0	no	0.9	0.75	no dnr	5	68	19	122	24	38.39844	225	1.799805	0.899902	1.199951	135	7.419922	98	31	2,630	0	0	no(M2 and SIP pres)	0
7,233	39.33499	0	male	0	85	713	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	227,671	142,435.625	157,445.125	36.25	white	27.699219	45	0.817993	0.757935	3	0	0	no	0.6	0.55	no dnr	85	65	13	124	30	37.79688	344	2.899902	0.899902	0.5	148	7.369141	119	6	4,310	null	1	adl>=4 (>=5 if sur)	1
7,234	61.99298	1	male	1	18	18	MOSF w/Malig	ARF/MOSF	2	12	under $11k	0	42,526	25,656.2812	29,635.5312	35.333313	white	28.597656	32	0.533936	0.418945	5	1	0	yes	0.15	0.1	dnr after sadm	8	66	8.5	101	40	38.69531	413.3125	2.299805	1.699951	0.899902	142	7.479492	270	24	2,620	null	0	<2 mo. follow-up	0
7,235	56.41898	1	male	1	50	50	MOSF w/Malig	ARF/MOSF	2	11	$25-$50k	0	98,742	65,428.8125	86,907.625	23.5	white	23.898438	36	0.711914	0.625	1	0	0	yes	0.5	0.2	dnr after sadm	10	107	8.898438	80	16	36.29688	319	4.299805	0.5	1.799805	137	7.469727	198	23	null	1	1	<2 mo. follow-up	1
7,236	33.63998	0	female	0	10	712	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	27,331	17,178.3125	18,940.8281	26	white	31.5	57	0.782959	0.712891	3	0	0	no	0.8	0.75	no dnr	10	113	11.898438	108	26	36.29688	276.1875	3.899902	0.399963	0.799927	138	7.359375	153	18	null	0	0	null	0
7,237	44.08798	1	male	0	5	492	CHF	COPD/CHF/Cirrhosis	3	16	under $11k	0	3,698	2,560.4688	2,859.44922	8	black	20.5	47	0.906982	0.842896	1	0	0	no	0.9	0.8	no dnr	5	120	10.099609	112	12	38.89844	154.53125	2.799805	2.099609	1.099854	131	7.399414	108	19	1,562	0	0	no(M2 and SIP pres)	0
7,238	50.95398	1	female	0	13	33	MOSF w/Malig	ARF/MOSF	3	10	$25-$50k	0	13,636	9,183.375	12,802.6172	13.5	white	33	37	0.500977	0.383972	1	1	0	yes	1	0.5	dnr before sadm	-1	130	18.199219	147	10	36.19531	182.125	3.099609	0.5	0.799927	133	7.219727	686	22	869	null	4	<2 mo. follow-up	4
7,239	75.78094	0	male	0	15	711	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	under $11k	0	31,215	20,074.5469	21,948.9375	26	black	29	70	0.625977	0.521973	4	0	0	no	0.75	0.7	no dnr	15	65	34.898438	101	22	39	376.1875	2.899902	1.599854	2	133	7.519531	151	61	1,875	null	0	no(M2 and SIP pres)	0
7,240	61.629	0	male	0	6	710	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	9	11,989	7,518.2695	8,195.22656	18	hispanic	13.599609	9	0.906982	0.872925	1	0	0	no	0.95	0.95	no dnr	6	105	4.399414	114	22	37.69531	358	1.599854	9.298828	0.699951	138	7.479492	75	9	1,166	null	0	null	0
7,241	53.37698	0	female	0	13	710	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	12,878	7,846.6602	8,019.04688	11.5	white	24.597656	30	0.834961	0.778931	1	0	0	no	0.9	0.9	no dnr	13	107	10.099609	65	9	36	400	2.199707	1.299805	10.298828	142	7.5	156	101	0	6	null	adl>=4 (>=5 if sur)	4.527344
7,242	64.23297	0	female	0	6	710	COPD	COPD/CHF/Cirrhosis	4	6	under $11k	0	5,989	4,009.6348	4,146.26953	4	white	14	18	0.894897	0.824951	1	0	0	yes	0.8	0.8	no dnr	6	0	18.5	0	8	33.59375	260	2.199707	10.298828	3.699707	144	7.419922	74	60	3	1	null	no(M2 and SIP pres)	1.166748
7,243	80.07098	1	female	1	17	17	ARF/MOSF w/Sepsis	ARF/MOSF	1	15	null	9	46,282	29,802.5625	35,356.0312	42	white	29.796875	47	0.567993	0.45697	2	0	0	no	0.5	0.2	dnr after sadm	8	122	13.599609	113	32	39.79688	165.6875	null	null	1	148	7.549805	114	22	3,525	null	0	<2 mo. follow-up	0
7,244	44.76398	0	male	0	5	708	Cirrhosis	COPD/CHF/Cirrhosis	4	12	under $11k	0	6,375	3,729.4258	4,725.96875	19	white	17.597656	27	0.884888	0.80896	1	0	0	no	0.95	0.95	no dnr	5	69	17.597656	146	9	37.89844	153.03125	2.399902	1.799805	1.5	140	7.289062	143	7	2,620	1	0	no(M2 and SIP pres)	0
7,245	57.90298	0	female	0	6	708	COPD	COPD/CHF/Cirrhosis	3	5	under $11k	0	6,613	4,251.0508	4,376.21875	16	white	24	37	0.85498	0.760986	1	1	0	no	0.9	0.9	no dnr	6	50	13.099609	101	10	36.39844	150	3	1	2.699707	126	7.459961	177	60	3,116	1	1	no(M2 and SIP pres)	1
7,246	53.96597	1	female	0	28	84	COPD	COPD/CHF/Cirrhosis	5	12	>$50k	0	53,536	32,119.7188	36,708.5312	29.25	white	24.199219	49	0.868896	0.782959	1	0	0	no	0.95	0.9	no dnr	28	106	25.097656	76	20	35.89844	null	4.599609	0.799927	1.199951	128	null	124	22	2,865	2	0	SIP>=30	0
7,247	89.58795	0	female	0	15	705	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	26	12,953	9,127.6875	10,176.9297	7.333332	black	22.199219	18	0.648926	0.549927	1	0	0	no	0.6	0.5	no dnr	15	65	5.099609	62	20	36.19531	null	2.199707	6.399414	1.199951	126	null	209	31	1,300	null	4	no(M2 and SIP pres)	4
7,248	37.689	0	female	0	7	704	Cirrhosis	COPD/CHF/Cirrhosis	2	11	under $11k	9	12,902	8,303.4297	9,418.44531	17	white	21.5	37	0.856934	0.763916	1	0	0	no	0.6	0.5	no dnr	7	60	8.099609	70	14	37.89844	null	1.399902	3.099609	0.899902	132	null	104	4	420	0	null	SIP>=30	0.494751
7,249	76.422	1	male	0	10	548	COPD	COPD/CHF/Cirrhosis	1	11	under $11k	9	15,849	9,946.5312	10,991.6484	19.5	black	14.398438	24	0.855957	0.761963	1	0	0	no	0.8	0.7	no dnr	10	57	16	127	10	36.19531	152	1.599854	3.299805	1.599854	135	7.419922	287	19	1,185	null	1	no(M2 and SIP pres)	1
7,250	34.69699	1	male	0	6	156	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	9	11,810	8,064.6641	9,610.40625	12	white	22.796875	34	0.859985	0.81189	5	0	0	no	0.8	0.7	no dnr	6	103	10.298828	126	16	36.19531	null	3.699707	0.299988	1.099854	130	null	90	12	null	null	1	no(M2 and SIP pres)	1
7,251	49.99899	0	female	0	15	702	ARF/MOSF w/Sepsis	ARF/MOSF	4	11	under $11k	0	18,604	11,809.9219	12,744.1562	18.333328	black	22	42	0.872925	0.827881	1	1	0	no	0.7	0.5	no dnr	15	107	6.899414	70	24	36.39844	null	4.299805	1.199951	1.799805	138	null	88	28	null	null	5	no(M2 and SIP pres)	5
7,252	25.31999	0	female	0	7	699	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	under $11k	0	21,874	15,546	16,455.1719	10	white	20.898438	29	0.901978	0.866943	10	0	0	no	0.95	0.95	no dnr	7	77	8.199219	52	16	36.19531	null	3.799805	0.599976	1.299805	126	null	86	18	2,885	0	3	no(M2 and SIP pres)	3
7,253	65.112	1	female	0	68	190	CHF	COPD/CHF/Cirrhosis	4	12	under $11k	0	78,561	50,516.25	58,854.6562	20.25	white	23.699219	33	0.816895	0.702881	1	1	0	no	0.1	0.05	no dnr	68	80	17.5	80	28	37.09375	240	2.399902	0.199982	1	136	7.489258	240	16	2,200	0	4	SIP>=30	4
7,254	55.797	0	female	0	7	699	CHF	COPD/CHF/Cirrhosis	4	12	$11-$25k	0	5,698	3,965.9062	4,049.62891	6.5	white	14.699219	10	0.92395	0.871948	1	0	0	no	0.6	0.6	no dnr	7	65	13.699219	144	36	36.29688	255.53125	1.799805	0.5	0.799927	133	7.489258	161	20	2,875	0	null	SIP>=30	0.494751
7,255	58.97897	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	under $11k	0	14,134	8,741.8984	10,157.2422	47	white	24.199219	49	0.730957	0.647949	1	0	0	metastatic	0.05	0	dnr after sadm	3	120	20.796875	133	10	39.29688	147.5	1.799805	0.699951	0.5	145	7.459961	335	14	2,614	null	6	<2 mo. follow-up	6
7,256	80.48499	1	male	0	7	310	ARF/MOSF w/Sepsis	ARF/MOSF	2	17	under $11k	0	8,545	5,517.5664	5,961.37891	11	white	22.097656	20	0.779907	0.708984	1	0	0	no	1	1	no dnr	7	106	0.099991	128	30	38.89844	160	3.199707	6.599609	4.799805	136	7.369141	113	99	2,075	1	null	SIP>=30	1.166748
7,257	33.60999	1	male	1	25	25	Coma	Coma	4	10	under $11k	44	69,568	35,766.9688	44,304.9062	27	black	27.398438	60	0.660889	0.602905	2	1	0	no	0.05	0.02	dnr after sadm	25	117	12.599609	61	32	38.39844	176	2	0.699951	0.899902	138	7.519531	133	25	4,059	null	1	<2 mo. follow-up	1
7,258	60.375	0	male	0	16	696	Cirrhosis	COPD/CHF/Cirrhosis	5	null	null	9	15,397	10,636.5703	11,346.8438	9.333328	white	22.398438	21	0.719971	0.563965	1	0	0	no	0.8	0.5	no dnr	16	62	18	101	26	35.89844	272	2.399902	1.799805	0.799927	121	7.399414	111	57	725	null	null	null	4.429688
7,259	62.67999	1	male	1	6	6	Cirrhosis	COPD/CHF/Cirrhosis	2	16	null	0	24,246	15,020.5391	17,635.75	51	white	30.898438	35	0.53894	0.340942	1	0	0	no	0.6	0.55	no dnr	6	162	19	135	8	39	194	5.599609	0.5	1.099854	135	7.169922	146	17	3,730	null	0	<2 mo. follow-up	0
7,260	26.18199	1	male	0	40	207	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	55,309	38,386.7188	46,836.7188	19	hispanic	19.796875	57	0.920898	0.891968	3	1	0	no	0.9	0.9	no dnr	40	116	13.699219	65	38	36	340	null	null	2	138	7.369141	64	33	2,300	7	7	SIP>=30	7
7,261	64.20294	0	male	0	4	695	COPD	COPD/CHF/Cirrhosis	2	18	under $11k	0	6,455	3,459.8203	4,053.46875	8	white	12.199219	22	0.927979	0.87793	1	0	0	no	0.6	0.5	no dnr	4	65	16.097656	123	8	36.29688	188	null	null	0.599976	128	7.489258	195	11	2,930	1	null	no(M2 and SIP pres)	1.166748
7,262	54.26099	1	male	1	4	4	Coma	Coma	3	9	under $11k	100	40,589	25,289.75	30,497.625	43	white	56.5	52	0	0	8	0	0	no	0	0	dnr after sadm	3	63	13.599609	129	14	36.79688	177.125	2.899902	0.399963	1.199951	138	7.299805	147	11	3,565	null	null	<2 mo. follow-up	3.377441
7,263	76.59094	0	male	0	5	694	CHF	COPD/CHF/Cirrhosis	5	12	under $11k	9	3,921	2,711.7344	3,071.71875	11	white	18.296875	14	0.784912	0.655884	1	1	0	yes	0.5	0.3	no dnr	5	102	11.099609	94	20	36	360	3.399902	0.899902	1.899902	136	7.479492	100	34	1,625	null	6	adl>=4 (>=5 if sur)	6
7,264	74.49396	1	female	0	13	163	MOSF w/Malig	ARF/MOSF	1	null	null	9	18,677	12,616	13,826.8672	16	white	24.5	37	0.507935	0.390991	4	0	0	metastatic	0	0	dnr after sadm	3	57	7.399414	133	8	35.59375	278	3	2.099609	0.299988	137	7.529297	86	18	700	null	null	null	3.882813
7,265	63.01398	1	male	1	41	41	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	$11-$25k	0	176,364	111,877.75	132,627.125	46.75	white	33.898438	56	0.529907	0.414978	15	0	0	no	0.6	0.5	dnr after sadm	36	75	10.099609	118	16	35.69531	372	3.399902	0.799927	1.799805	136	7.469727	92	19	2,675	null	0	<2 mo. follow-up	0
7,266	58.87997	1	female	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	3	10	under $11k	0	61,942	31,753.5	38,041.0625	24	white	32.898438	46	0.598999	0.490967	9	1	0	no	0.2	0.1	dnr after sadm	6	109	20.199219	107	38	36.29688	208.5625	3.399902	1.5	0.899902	137	7.449219	133	26	2,420	null	1	<2 mo. follow-up	1
7,267	49.98798	1	male	0	5	137	Lung Cancer	Cancer	1	12	$25-$50k	0	8,300	5,627.6602	6,072.76953	11	white	9.599609	15	0.848999	0.666992	1	0	0	metastatic	0.9	0.4	no dnr	5	82	14.699219	107	28	38.69531	183.84375	3.299805	3.299805	1	128	7.399414	134	24	4,100	null	null	no(M2 and SIP pres)	2.093262
7,268	72.28699	1	male	0	13	309	COPD	COPD/CHF/Cirrhosis	1	10	under $11k	0	25,326	16,010.8594	20,143.9688	11	white	23.199219	29	0.721924	0.566895	11	0	0	no	0.5	0.35	dnr before sadm	-1	101	11.199219	100	20	36.29688	261.875	4	1.399902	0.799927	136	7.40918	94	13	null	2	null	SIP>=30	1.838867
7,269	38.66098	0	male	0	27	689	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	68,693	43,661.0312	53,243.7812	41.5	white	29.796875	43	0.800903	0.734985	2	0	0	no	0.85	0.85	no dnr	27	114	8.199219	150	50	36	136	2.799805	0.5	1	135	7.379883	248	20	2,505	null	0	SIP>=30	0
7,270	49.202	1	male	0	34	37	CHF	COPD/CHF/Cirrhosis	3	null	under $11k	9	30,122	21,783.8438	24,751.8281	13.5	black	35.195313	52	0.66394	0.488953	1	0	0	no	0.9	0.6	dnr after sadm	5	133	8.298828	116	10	35.09375	167.71875	3.299805	1.5	0.799927	140	7.389648	114	19	2,716	null	6	<2 mo. follow-up	6
7,271	55.29099	1	female	1	18	18	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	9	56,771	35,733.5	41,528.3438	42	white	25.796875	47	0.751953	0.672974	5	0	0	no	0.3	0.25	dnr after sadm	18	99	4.699219	88	20	36.89844	180	4.399414	0.5	1.399902	131	7.349609	105	16	null	6	6	<2 mo. follow-up	6
7,272	72.047	1	female	0	6	637	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	4,441	3,018.7148	3,359.75977	8	white	25	33	0.770996	0.634888	1	1	0	no	1	1	no dnr	6	63	49.296875	77	22	36.19531	596	1.799805	0.5	3.699707	137	7.369141	205	53	1,605	1	2	no(M2 and SIP pres)	2
7,273	68.94995	1	male	0	21	46	Cirrhosis	COPD/CHF/Cirrhosis	4	12	$11-$25k	37	32,833	21,437.5469	23,775.75	26	white	22.398438	44	0.530884	0.330994	1	1	0	no	0.6	0.3	no dnr	21	128	13.798828	133	6	38	155	3.299805	0.5	1.099854	142	7.319336	106	13	1,492	1	4	<2 mo. follow-up	4
7,274	35.918	1	female	0	14	549	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$25-$50k	0	18,968	12,872.1094	14,176.5859	17	white	36.398438	62	0.716919	0.630981	1	1	0	no	0.5	0.5	no dnr	14	126	6.599609	107	20	36	null	3.099609	1	1.299805	134	null	193	19	400	0	5	SIP>=30	5
7,275	31.625	0	male	0	97	687	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$25-$50k	0	149,704	96,637.25	106,533.5	45.5	black	21.597656	20	0.888916	0.849976	1	0	0	yes	0.9	0.9	no dnr	97	119	8.298828	50	22	36.5	247.59375	3.599609	0.599976	1.099854	137	7.439453	107	24	null	null	6	adl>=4 (>=5 if sur)	6
7,276	66.81494	0	female	0	4	685	COPD	COPD/CHF/Cirrhosis	0	12	under $11k	0	5,201	null	null	8	white	12.798828	9	0.916992	0.859985	1	0	0	no	1	1	no dnr	4	79	7.799805	64	16	36.39844	null	4.599609	0.699951	0.899902	135	null	96	13	900	0	null	no(M2 and SIP pres)	0.494751
7,277	63.89899	1	female	0	5	17	Lung Cancer	Cancer	1	9	under $11k	9	4,045	2,675.9766	3,266.0293	12	black	33.398438	23	0.227997	0.025997	1	0	0	metastatic	0.3	0.05	dnr before sadm	-1	53	21.097656	132	12	38.5	108.32812	1.599854	1	1.299805	134	7.439453	296	36	2,755	2	null	<2 mo. follow-up	1.838867
7,278	72.77197	1	male	0	10	226	Cirrhosis	COPD/CHF/Cirrhosis	3	9	under $11k	0	12,968	8,341.4062	9,802.61719	10.5	black	20.699219	26	0.69397	0.528931	1	0	0	no	0.8	0.8	no dnr	10	139	1.399902	167	32	32	154	4.299805	0.799927	2.099609	132	7.419922	196	24	3,685	1	1	no(M2 and SIP pres)	1
7,279	59.62997	0	female	0	3	684	CHF	COPD/CHF/Cirrhosis	4	12	under $11k	0	2,429	1,262.1367	1,230.64941	null	black	8.199219	11	0.950928	0.914917	1	1	0	no	null	null	no dnr	3	138	13.798828	129	10	38.39844	66	3	12.298828	0.799927	135	7.469727	147	11	2,385	1	null	SIP>=30	1.166748
7,280	56.60199	1	male	0	19	401	COPD	COPD/CHF/Cirrhosis	2	null	under $11k	0	42,496	26,078.9531	29,160.4688	28.333328	white	25.199219	36	0.846924	0.747925	1	0	0	no	0.8	0.7	no dnr	19	99	18.5	100	24	36.89844	137.5	3	1	2.299805	142	7.349609	232	46	1,175	null	1	no(M2 and SIP pres)	1
7,281	69.21594	1	female	0	40	381	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	under $11k	0	76,690	48,881.5938	55,026.6875	35	white	17.5	37	0.871948	0.827881	1	1	0	no	0.9	0.9	no dnr	40	115	9.798828	80	12	37.89844	171.09375	2.199707	1.799805	2.799805	137	7.509766	99	40	1,253	null	null	null	2.608398
7,282	79.81696	0	male	0	114	679	ARF/MOSF w/Sepsis	ARF/MOSF	0	9	under $11k	0	252,121	162,134.5	197,409.25	58.25	white	29.898438	44	0.590942	0.482971	3	0	0	no	0.35	0.25	dnr after sadm	12	83	7.099609	78	20	36.5	304.75	3.899902	0.599976	1.299805	135	7.459961	395	13	null	null	0	adl>=4 (>=5 if sur)	0
7,283	70.81195	1	female	0	5	245	Lung Cancer	Cancer	1	9	under $11k	0	3,972	2,684.6875	3,825.29883	6	white	9.298828	33	0.822998	0.616943	1	0	0	metastatic	0.7	0.2	dnr after sadm	5	139	17.699219	131	35	39.09375	173.3125	2.5	0.399963	1.199951	153	7.419922	280	18	6,520	0	null	adl>=4 (>=5 if sur)	0.494751
7,284	57.88098	1	male	0	11	394	CHF	COPD/CHF/Cirrhosis	1	12	$11-$25k	0	8,814	6,131.707	6,662.45703	7	black	18.199219	31	0.895996	0.824951	1	0	0	no	0.5	0.3	dnr after sadm	4	112	3	153	6	37.89844	160	3	0.5	1	150	7.539062	273	10	4,029	0	0	no(M2 and SIP pres)	0
7,285	91.64398	1	female	0	3	241	CHF	COPD/CHF/Cirrhosis	3	8	under $11k	0	2,938	1,826.9522	2,093.66992	null	other	22.398438	25	0.659912	0.483948	1	0	0	yes	1	1	no dnr	3	73	9.099609	80	22	36.19531	512	null	null	1	138	7.449219	124	12	2,050	0	null	no(M2 and SIP pres)	0.494751
7,286	82.06696	1	male	0	10	28	CHF	COPD/CHF/Cirrhosis	2	2	under $11k	0	11,305	6,523.6172	7,900.24609	13.5	white	23.296875	38	0.753906	0.610962	1	0	0	no	0.5	0.4	dnr after sadm	4	103	5.599609	74	15	35.69531	182.84375	2.299805	0.5	5.899414	135	7.419922	147	56	2,425	0	0	<2 mo. follow-up	0
7,287	58.198	0	male	0	9	677	CHF	COPD/CHF/Cirrhosis	3	13	under $11k	9	9,942	6,615.8359	7,824.79688	10	white	13.5	20	0.917969	0.860962	1	0	0	no	0.9	0.9	no dnr	9	75	53.398438	69	20	36.29688	null	2.5	0.699951	2.399902	132	null	152	75	3,200	null	0	null	0
7,288	67.71796	1	male	0	3	158	Lung Cancer	Cancer	2	10	$25-$50k	0	3,124	2,075.2617	2,383.05859	null	white	17.398438	7	0.69397	0.404968	1	0	0	metastatic	0.9	0.6	no dnr	3	71	10.199219	138	51	39.19531	142.5	2.399902	0.899902	1.5	147	7.419922	147	31	4,132	null	null	null	2.623535
7,289	51.04199	0	female	0	9	675	MOSF w/Malig	ARF/MOSF	2	null	null	0	24,722	15,592.6641	17,421.125	33	hispanic	23.5	38	0.642944	0.541992	2	0	0	metastatic	null	null	no dnr	9	109	8.099609	72	20	36	null	3.599609	2	2.199707	135	null	84	45	2.47998	null	null	null	3.728027
7,290	54.34399	0	male	0	5	675	CHF	COPD/CHF/Cirrhosis	3	16	under $11k	0	3,456	2,491.1348	2,705.87891	12	black	25.796875	24	0.828979	0.720947	1	1	0	no	0.9	0.8	no dnr	5	78	10.699219	120	20	36.89844	null	2.5	3.299805	0.799927	119	null	426	15	1,200	0	0	no(M2 and SIP pres)	0
7,291	70.57898	0	female	0	35	675	Coma	Coma	0	12	under $11k	9	100,540	66,278.8125	75,486.0625	23.5	white	20.296875	15	0.60498	0.540894	13	0	0	no	0.8	0.8	no dnr	35	61	15.398438	126	42	36.59375	313.3125	2.099609	0.599976	6.5	144	7.359375	55	65	1,860	null	0	no(M2 and SIP pres)	0
7,292	69.36597	1	male	1	19	19	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$11-$25k	0	64,100	33,446.375	40,356.75	50.333313	white	37.796875	81	0.416992	0.297974	5	0	0	no	0.1	0.1	no dnr	19	77	8.199219	82	24	36.59375	230.53125	3.099609	1.399902	1.199951	139	7.379883	105	14	2,260	null	1	<2 mo. follow-up	1
7,293	74.06696	1	male	0	34	36	ARF/MOSF w/Sepsis	ARF/MOSF	4	11	under $11k	0	73,698	46,554.7812	53,819.0938	37.5	white	23.699219	39	0.728882	0.645996	1	1	0	yes	0.5	0.5	dnr after sadm	26	99	15	118	28	38.19531	314.25	4.899414	1.5	0.399963	141	7.359375	95	7	770	null	6	<2 mo. follow-up	6
7,294	74.51599	1	female	1	15	15	MOSF w/Malig	ARF/MOSF	2	13	under $11k	26	48,918	30,905.7188	40,094.625	41.666657	white	30.199219	64	0.234985	0.134979	6	0	0	metastatic	0.1	0.001	dnr after sadm	6	64	7.899414	62	22	36.69531	266.625	3.899902	0.699951	0.799927	148	7.399414	152	18	2,950	null	0	<2 mo. follow-up	0
7,295	76.87897	1	female	0	41	44	ARF/MOSF w/Sepsis	ARF/MOSF	1	6	under $11k	0	60,870	39,182.9688	51,347.5312	28.75	white	17.597656	13	0.821899	0.761963	5	0	0	no	0.6	0.6	dnr before sadm	-1	66	3	130	32	35.69531	334	1.399902	1	1.5	143	7.489258	80	33	2,026	null	7	<2 mo. follow-up	7
7,296	74.133	0	male	0	6	671	COPD	COPD/CHF/Cirrhosis	4	12	under $11k	9	6,695	4,200.4609	4,611.79688	12	white	20.097656	26	0.795898	0.671997	1	0	0	no	0.75	0.65	no dnr	6	106	5.399414	101	30	36.59375	null	2.099609	1.099854	0.899902	139	null	105	11	1,475	6	1	SIP>=30	1
7,297	49.18799	0	male	0	6	670	Lung Cancer	Cancer	1	12	under $11k	0	6,588	4,471.5078	5,689.28906	15	white	15.398438	20	0.770996	0.523926	1	0	0	metastatic	0.9	0.7	no dnr	6	69	11.199219	105	24	35.59375	185.6875	3.599609	0.899902	0.899902	133	7.269531	422	13	3,490	0	null	null	0.494751
7,298	72.81598	1	female	0	11	308	Lung Cancer	Cancer	1	6	under $11k	0	12,796	8,688.625	12,170.4297	7	white	16.699219	13	0.695923	0.406982	1	0	0	metastatic	0.25	0.05	dnr after sadm	2	130	15.099609	126	12	36.39844	140.71875	4.199219	0.199982	1.599854	133	7.209961	240	33	null	2	0	adl>=4 (>=5 if sur)	0
7,299	89.20996	1	male	0	5	667	MOSF w/Malig	ARF/MOSF	1	20	null	0	5,806	4,143.7969	5,598.34766	6	white	24.597656	37	0.598999	0.490967	4	0	0	yes	0.7	0.5	no dnr	5	120	11.798828	124	10	37.19531	142.5	null	null	0.899902	141	7.449219	140	30	1,750	2	0	no(M2 and SIP pres)	0
7,300	35.90399	0	female	0	7	669	Colon Cancer	Cancer	1	10	$11-$25k	0	7,600	5,096.7812	6,326.53906	7.5	black	7.5	23	0.934937	0.845947	1	0	0	metastatic	0.5	0.2	no dnr	7	105	11.398438	104	24	36.19531	null	3.599609	0.699951	1.199951	154	7.399414	437	19	1,750	1	0	no(M2 and SIP pres)	0

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.